OpenAI acquires Orchestra Bio
OpenAI acquired Orchestra Bio, a drug-development platform, to join its Rosalind life sciences tools.
OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.
Official source
OpenAI acquires Orchestra Bioopenai.com · published